Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22828481 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z)
Condition: Pulmonary Tuberculosis
Interventions: Drug: PA-824;   Drug: Pyrazinamide;   Drug: TMC207;   Drug: Rifafour;   Drug: Moxifloxacin

Indicates status has not been verified in more than two years